Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 961.40
-25.80 (-2.61%)
At close: Mar 23, 2026
Laurus Labs Revenue
Laurus Labs had revenue of 17.78B INR in the quarter ending December 31, 2025, with 25.67% growth. This brings the company's revenue in the last twelve months to 67.22B, up 27.46% year-over-year. In the fiscal year ending March 31, 2025, Laurus Labs had annual revenue of 55.54B with 10.18% growth.
Revenue (ttm)
67.22B
Revenue Growth
+27.46%
P/S Ratio
7.72
Revenue / Employee
10.90M
Employees
6,167
Market Cap
519.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 55.54B | 5.13B | 10.18% |
| Mar 31, 2024 | 50.41B | -10.00B | -16.55% |
| Mar 31, 2023 | 60.41B | 11.05B | 22.39% |
| Mar 31, 2022 | 49.36B | 1.22B | 2.54% |
| Mar 31, 2021 | 48.14B | 19.82B | 69.99% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 331.82B |
| Cipla | 279.67B |
| Zydus Lifesciences | 260.89B |
| Glenmark Pharmaceuticals | 165.10B |
| Alkem Laboratories | 142.53B |
| Mankind Pharma | 139.14B |
| Divi's Laboratories | 103.14B |
| Ipca Laboratories | 95.06B |
Laurus Labs News
- 3 days ago - Pharma sector stocks surge today, March 20: Laurus Labs jumps 2.83%, Natco Pharma up 2.67%, Aurobindo Pharma gains 2.42% - Business Upturn
- 4 days ago - Pharma sector stocks fall today, March 19: Biocon down 2.33%, Laurus Labs falls 2.29%, Glenmark Pharma drops 2% - Business Upturn
- 10 days ago - Pharma sector stocks today, March 13: Laurus Labs down 2.56%, Ajanta Pharma falls 1.88%, Granules India drops 2.14% - Business Upturn
- 14 days ago - Pharma sector fall sharply otday, March 9: Laurus Labs down 3%, Glenmark Pharma drops 2.44%, Zydus Life falls 2.10% - Business Upturn
- 2 months ago - Laurus Labs Ltd (BOM:540222) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 2 months ago - Q3 2026 Laurus Labs Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Laurus Labs betting big on CDMO segment to power future growth - The Times of India
- 3 months ago - GAIL, Swiggy & more: Top stocks to buy on December 2 — check list - The Times of India